[Department of Error] Department of Error
Giles TD, Weber MA, Basile J, et al, for the NAC-MD-01 Study Investigators. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study. Lancet 2014; 383: 1889–98—In figures 2A and 2B of this Article, the first fixed-dose combination bars labelled as “FDC 10 and 80 mg/day” should be labelled as “FDC 10 and 160 mg/day”. These corrections have been made to the online version as of Sept 22, 2016.